Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond

Radiotherapy is an essential component of multi-modality treatment of glioblastoma (GBM). However, treatment failure and recurrence are frequent and give rise to the dismal prognosis of this aggressive type of primary brain tumor. A high level of inherent treatment resistance is considered to be the...

Descripción completa

Detalles Bibliográficos
Autores principales: Orth, Michael, Albrecht, Valerie, Seidl, Karin, Kinzel, Linda, Unger, Kristian, Hess, Julia, Kreutzer, Lisa, Sun, Na, Stegen, Benjamin, Nieto, Alexander, Maas, Jessica, Winssinger, Nicolas, Friedl, Anna A., Walch, Axel K., Belka, Claus, Zitzelsberger, Horst, Niyazi, Maximilian, Lauber, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011354/
https://www.ncbi.nlm.nih.gov/pubmed/33816244
http://dx.doi.org/10.3389/fonc.2021.612354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011354/
https://www.ncbi.nlm.nih.gov/pubmed/33816244
http://dx.doi.org/10.3389/fonc.2021.612354

Ejemplares similares